751 related articles for article (PubMed ID: 27270872)
21. The effect of curcumin with piperine supplementation on pro-oxidant and antioxidant balance in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial.
Mirhafez SR; Farimani AR; Gholami A; Hooshmand E; Tavallaie S; Nobakht M Gh BF
Drug Metab Pers Ther; 2019 May; 34(2):. PubMed ID: 31145689
[TBL] [Abstract][Full Text] [Related]
22. Effects of vitamin D supplementation on liver fibrogenic factors in non-alcoholic fatty liver patients with steatohepatitis: study protocol for a randomized clinical trial.
Ebrahimpour-Koujan S; Sohrabpour AA; Foroughi F; Alvandi E; Esmaillzadeh A
Trials; 2019 Mar; 20(1):153. PubMed ID: 30832722
[TBL] [Abstract][Full Text] [Related]
23. No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
Barchetta I; Del Ben M; Angelico F; Di Martino M; Fraioli A; La Torre G; Saulle R; Perri L; Morini S; Tiberti C; Bertoccini L; Cimini FA; Panimolle F; Catalano C; Baroni MG; Cavallo MG
BMC Med; 2016 Jun; 14():92. PubMed ID: 27353492
[TBL] [Abstract][Full Text] [Related]
24. Is There a Role for Curcumin Supplementation in the Treatment of Non-Alcoholic Fatty Liver Disease? The Data Suggest Yes.
Zabihi NA; Pirro M; Johnston TP; Sahebkar A
Curr Pharm Des; 2017; 23(7):969-982. PubMed ID: 27748192
[TBL] [Abstract][Full Text] [Related]
25. Curcumin and Piperine Combination for the Treatment of Patients with Non-alcoholic Fatty Liver Disease: A Double-Blind Randomized Placebo-Controlled Trial.
Mirhafez SR; Dehabeh M; Hariri M; Farimani AR; Movahedi A; Naderan RD; Jamialahmadi T; Simental-Mendía LE; Sahebkar A
Adv Exp Med Biol; 2021; 1328():11-19. PubMed ID: 34981468
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of phospholipidated curcumin in nonalcoholic fatty liver disease: a clinical study.
Panahi Y; Kianpour P; Mohtashami R; Soflaei SS; Sahebkar A
J Asian Nat Prod Res; 2019 Aug; 21(8):798-805. PubMed ID: 30415581
[TBL] [Abstract][Full Text] [Related]
27. Vitamin D supplementation for the treatment of non-alcoholic fatty liver disease: A randomized double blind placebo controlled trial.
Dabbaghmanesh MH; Danafar F; Eshraghian A; Omrani GR
Diabetes Metab Syndr; 2018 Jul; 12(4):513-517. PubMed ID: 29588137
[TBL] [Abstract][Full Text] [Related]
28. Curcumin Offers No Additional Benefit to Lifestyle Intervention on Cardiometabolic Status in Patients with Non-Alcoholic Fatty Liver Disease.
Naseri K; Saadati S; Yari Z; Askari B; Mafi D; Hoseinian P; Asbaghi O; Hekmatdoost A; de Courten B
Nutrients; 2022 Aug; 14(15):. PubMed ID: 35956400
[TBL] [Abstract][Full Text] [Related]
29. Effect of sour tea supplementation on liver enzymes, lipid profile, blood pressure, and antioxidant status in patients with non-alcoholic fatty liver disease: A double-blind randomized controlled clinical trial.
Izadi F; Farrokhzad A; Tamizifar B; Tarrahi MJ; Entezari MH
Phytother Res; 2021 Jan; 35(1):477-485. PubMed ID: 32909326
[TBL] [Abstract][Full Text] [Related]
30. Effect of garlic powder supplementation on hepatic steatosis, liver enzymes and lipid profile in patients with non-alcoholic fatty liver disease: a double-blind randomised controlled clinical trial.
Sangouni AA; Mohammad Hosseini Azar MR; Alizadeh M
Br J Nutr; 2020 Aug; 124(4):450-456. PubMed ID: 32312333
[TBL] [Abstract][Full Text] [Related]
31. A Randomized Trial of Silymarin for the Treatment of Nonalcoholic Steatohepatitis.
Wah Kheong C; Nik Mustapha NR; Mahadeva S
Clin Gastroenterol Hepatol; 2017 Dec; 15(12):1940-1949.e8. PubMed ID: 28419855
[TBL] [Abstract][Full Text] [Related]
32. Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial.
Mofidi F; Poustchi H; Yari Z; Nourinayyer B; Merat S; Sharafkhah M; Malekzadeh R; Hekmatdoost A
Br J Nutr; 2017 Mar; 117(5):662-668. PubMed ID: 28345499
[TBL] [Abstract][Full Text] [Related]
33. Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight/obese patients with NAFLD? A randomised, double-blind, placebo-controlled, clinical trial.
Namkhah Z; Naeini F; Mahdi Rezayat S; Mehdi Yaseri ; Mansouri S; Javad Hosseinzadeh-Attar M
Int J Clin Pract; 2021 Nov; 75(11):e14852. PubMed ID: 34516703
[TBL] [Abstract][Full Text] [Related]
34. Effects of curcumin/turmeric supplementation on the liver enzymes, lipid profiles, glycemic index, and anthropometric indices in non-alcoholic fatty liver patients: An umbrella meta-analysis.
Molani-Gol R; Dehghani A; Rafraf M
Phytother Res; 2024 Feb; 38(2):539-555. PubMed ID: 37918958
[TBL] [Abstract][Full Text] [Related]
35. Regression of Non-Alcoholic Fatty Liver by Vitamin D Supplement: A Double-Blind Randomized Controlled Clinical Trial.
Lorvand Amiri H; Agah S; Mousavi SN; Hosseini AF; Shidfar F
Arch Iran Med; 2016 Sep; 19(9):631-8. PubMed ID: 27631178
[TBL] [Abstract][Full Text] [Related]
36. Turmeric Supplementation Improves Serum Glucose Indices and Leptin Levels in Patients with Nonalcoholic Fatty Liver Diseases.
Navekar R; Rafraf M; Ghaffari A; Asghari-Jafarabadi M; Khoshbaten M
J Am Coll Nutr; 2017; 36(4):261-267. PubMed ID: 28443702
[TBL] [Abstract][Full Text] [Related]
37. A pilot study of the effect of curcumin on epigenetic changes and DNA damage among patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled, clinical trial.
Hariri M; Gholami A; Mirhafez SR; Bidkhori M; Sahebkar A
Complement Ther Med; 2020 Jun; 51():102447. PubMed ID: 32507446
[TBL] [Abstract][Full Text] [Related]
38. Genistein supplementation improves insulin resistance and inflammatory state in non-alcoholic fatty liver patients: A randomized, controlled trial.
Amanat S; Eftekhari MH; Fararouei M; Bagheri Lankarani K; Massoumi SJ
Clin Nutr; 2018 Aug; 37(4):1210-1215. PubMed ID: 28647291
[TBL] [Abstract][Full Text] [Related]
39. Effect of daily calcitriol supplementation with and without calcium on disease regression in non-alcoholic fatty liver patients following an energy-restricted diet: Randomized, controlled, double-blind trial.
Lorvand Amiri H; Agah S; Tolouei Azar J; Hosseini S; Shidfar F; Mousavi SN
Clin Nutr; 2017 Dec; 36(6):1490-1497. PubMed ID: 27720403
[TBL] [Abstract][Full Text] [Related]
40. The effect of alpha-lipoic acid on inflammatory markers and body composition in obese patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial.
Hosseinpour-Arjmand S; Amirkhizi F; Ebrahimi-Mameghani M
J Clin Pharm Ther; 2019 Apr; 44(2):258-267. PubMed ID: 30585337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
